These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 24559750

  • 41. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S, Wilasrusmee C, Lertsitichai P, Phromsopha N.
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [Abstract] [Full Text] [Related]

  • 42. Arterial enhancing-only nodules less than 2 cm in diameter in patients with liver cirrhosis: predictors of hepatocellular carcinoma diagnosis on gadobenate dimeglumine-enhanced MR imaging.
    Quaia E, Pizzolato R, De Paoli L, Angileri R, Ukmar M, Cova MA.
    J Magn Reson Imaging; 2013 Apr; 37(4):892-902. PubMed ID: 23097278
    [Abstract] [Full Text] [Related]

  • 43. MR features of small hepatocellular carcinoma in normal, fibrotic, and cirrhotic livers: a comparative study.
    Sheng RF, Zeng MS, Ji Y, Yang L, Chen CZ, Rao SX.
    Abdom Imaging; 2015 Oct; 40(8):3062-9. PubMed ID: 26329976
    [Abstract] [Full Text] [Related]

  • 44. Combined hepatocellular and cholangiocellular carcinoma.
    Murakami T, Kim T, Tomoda K, Narumi Y, Sakon M, Wakasa K, Nakamura H.
    Radiat Med; 1997 Oct; 15(4):243-6. PubMed ID: 9311042
    [Abstract] [Full Text] [Related]

  • 45. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis].
    Hu JY, Zhou HB, Liu WD, Zhang J, Hu HP, Liu J.
    Zhonghua Gan Zang Bing Za Zhi; 2019 Jul 20; 27(7):511-515. PubMed ID: 31357776
    [Abstract] [Full Text] [Related]

  • 46. Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI?
    Al Ansari N, Kim BS, Srirattanapong S, Semelka CT, Ramalho M, Altun E, Woosley JT, Calvo B, Semelka RC.
    Abdom Imaging; 2014 Dec 20; 39(6):1228-40. PubMed ID: 24929668
    [Abstract] [Full Text] [Related]

  • 47. Magnetic resonance imaging of cholangiocarcinoma.
    Manfredi R, Barbaro B, Masselli G, Vecchioli A, Marano P.
    Semin Liver Dis; 2004 May 20; 24(2):155-64. PubMed ID: 15192788
    [Abstract] [Full Text] [Related]

  • 48. Detection of hepatocellular carcinoma arising in cirrhotic livers: comparison of gadolinium- and ferumoxides-enhanced MR imaging.
    Tang Y, Yamashita Y, Arakawa A, Namimoto T, Mitsuzaki K, Abe Y, Katahira K, Takahashi M.
    AJR Am J Roentgenol; 1999 Jun 20; 172(6):1547-54. PubMed ID: 10350287
    [Abstract] [Full Text] [Related]

  • 49. Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
    Li R, Cai P, Ma KS, Ding SY, Guo DY, Yan XC.
    Sci Rep; 2016 May 26; 6():26772. PubMed ID: 27226026
    [Abstract] [Full Text] [Related]

  • 50. [A case of combined liver cell and bile duct carcinoma detected 6 years after interferon therapy for chronic hepatitis C, in spite of showing complete response].
    Morizono S, Fukutomi M, Yokota M, Iguchi H, Funakoshi A, Wakasugi H, Ikeda Y, Hachitanda Y.
    Nihon Shokakibyo Gakkai Zasshi; 2002 May 26; 99(5):505-10. PubMed ID: 12048895
    [No Abstract] [Full Text] [Related]

  • 51. Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients.
    Vilgrain V, Van Beers BE, Flejou JF, Belghiti J, Delos M, Gautier AL, Zins M, Denys A, Menu Y.
    J Comput Assist Tomogr; 1997 May 26; 21(1):59-65. PubMed ID: 9022771
    [Abstract] [Full Text] [Related]

  • 52. [In vivo proton magnetic resonance spectroscopy of hepatocellular carcinoma and cholangiocarcinoma].
    Dong AS, Tian JM, Lu JP, Zuo CJ, Wang L, Wang J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr 26; 31(2):151-4. PubMed ID: 19507591
    [Abstract] [Full Text] [Related]

  • 53. Multiarterial phase dynamic MRI of small early enhancing hepatic lesions in cirrhosis or chronic hepatitis: differentiating between hypervascular hepatocellular carcinomas and pseudolesions.
    Ito K, Fujita T, Shimizu A, Koike S, Sasaki K, Matsunaga N, Hibino S, Yuhara M.
    AJR Am J Roentgenol; 2004 Sep 26; 183(3):699-705. PubMed ID: 15333358
    [Abstract] [Full Text] [Related]

  • 54. [Usefulness of 3DFT-FISP MR imaging in differential diagnosis of liver tumor].
    Ishida T, Murakami T, Nakamura H, Tsuda K, Nakanishi K, Hori S, Tomoda K, Mitani T, Hashimoto T, Kozuka T.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Feb 25; 54(2):101-8. PubMed ID: 8121775
    [Abstract] [Full Text] [Related]

  • 55. Gadoxetic acid disodium-enhanced MR imaging of cholangiolocellular carcinoma of the liver: imaging characteristics and histopathological correlations.
    Haradome H, Unno T, Morisaka H, Toda Y, Kwee TC, Kondo H, Sano K, Ichikawa T, Kondo F, Sugitani M, Takayama T.
    Eur Radiol; 2017 Nov 25; 27(11):4461-4471. PubMed ID: 28439650
    [Abstract] [Full Text] [Related]

  • 56. Cholangiolocellular carcinoma of the liver: CT and MR findings.
    Fukukura Y, Hamanoue M, Fujiyoshi F, Sasaki M, Haruta K, Inoue H, Aiko T, Nakajo M.
    J Comput Assist Tomogr; 2000 Nov 25; 24(5):809-12. PubMed ID: 11045707
    [Abstract] [Full Text] [Related]

  • 57. Additional value of SPIO-enhanced MR imaging for the noninvasive imaging diagnosis of hepatocellular carcinoma in cirrhotic liver.
    Yoo HJ, Lee JM, Lee JY, Kim SH, Kim SJ, Han JK, Choi BI.
    Invest Radiol; 2009 Dec 25; 44(12):800-7. PubMed ID: 19838119
    [Abstract] [Full Text] [Related]

  • 58. Atypical Appearance of Hepatocellular Carcinoma and Its Mimickers: How to Solve Challenging Cases Using Gadoxetic Acid-Enhanced Liver Magnetic Resonance Imaging.
    Kim JH, Joo I, Lee JM.
    Korean J Radiol; 2019 Jul 25; 20(7):1019-1041. PubMed ID: 31270973
    [Abstract] [Full Text] [Related]

  • 59. Bile duct involvement in hepatocellular carcinoma: MR demonstration.
    Soyer P, Laissy JP, Bluemke DA, Sibert A, Menu Y.
    Abdom Imaging; 1995 Jul 25; 20(2):118-21. PubMed ID: 7787712
    [Abstract] [Full Text] [Related]

  • 60. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma.
    Chen L, Zeng F, Yao L, Fang T, Liao M, Long J, Xiao L, Deng G.
    Cancer Med; 2020 Feb 25; 9(4):1451-1461. PubMed ID: 31903730
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.